I agree that this site is using cookies. You can find further informations here.
X
Tamada, Satoshi
212  results:
Search for persons X
?
1

Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  84 (2023)  5 - p. e123-e124 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Pembrolizumab Plus Axitinib Versus Sunitinib as First-line ..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  84 (2023)  5 - p. 449-454 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Corrigendum to "Pembrolizumab Plus Axitinib Versus Sunitini..:

Plimack, Elizabeth R. ; Powles, Thomas ; Stus, Viktor...
European Urology.  , 2023
Link: https://doi.org/10.1016/..
 
?
4

Final efficacy and safety results and biomarker analysis of..:

Nakaigawa, Noboru ; Tomita, Yoshihiko ; Tamada, Satoshi...
International Journal of Clinical Oncology.  28 (2023)  3 - p. 416-426 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Phase I/II study of multipeptide cancer vaccine IMA901 afte..:

Hongo, Fumiya ; Ueda, Takashi ; Takaha, Natsuki...
International Journal of Urology.  30 (2022)  2 - p. 176-180 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Prognostic value of PD-L1 expression in recurrent renal cel..:

Tamada, Satoshi ; Nozawa, Masahiro ; Ohba, Kojiro...
International Journal of Clinical Oncology.  28 (2022)  2 - p. 289-298 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Pathologic complete response with pembrolizumab plus axitin..:

Shimizu, Kazuki ; Tamada, Satoshi ; Matsuoka, Yudai...
International Cancer Conference Journal.  11 (2022)  3 - p. 205-209 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Health-related Quality of Life Analysis from KEYNOTE-426: P..:

Bedke, Jens ; Rini, Brian I. ; Plimack, Elizabeth R....
European Urology.  82 (2022)  4 - p. 427-439 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Lenvatinib plus pembrolizumab versus sunitinib for advanced..:

Eto, Masatoshi ; Takagi, Toshio ; Kimura, Go...
Cancer Medicine.  12 (2022)  6 - p. 6902-6912 , 2022
Link: https://doi.org/10.1002/..
 
?
10

Kamikihito improves cancer‐related fatigue in castration‐re..:

Tamada, Satoshi ; Iguchi, Taro ; Kato, Minoru...
Traditional & Kampo Medicine.  8 (2021)  3 - p. 204-210 , 2021
Link: https://doi.org/10.1002/..
 
?
11

Pembrolizumab plus axitinib versus sunitinib in metastatic ..:

Tamada, Satoshi ; Kondoh, Chihiro ; Matsubara, Nobuaki...
International Journal of Clinical Oncology.  27 (2021)  1 - p. 154-164 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Myeloid-derived suppressor cells are essential partners for..:

Takeyama, Yuji ; Kato, Minoru ; Tamada, Satoshi...
Cancer Letters.  479 (2020)  - p. 89-99 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Editorial Comment to Efficacy and safety of first‐line nivo..:

Tamada, Satoshi
International Journal of Urology.  27 (2020)  12 - p. 1100-1101 , 2020
Link: https://doi.org/10.1111/..
 
?
14

Cabozantinib in advanced renal cell carcinoma: A phase II, ..:

Tomita, Yoshihiko ; Tatsugami, Katsunori ; Nakaigawa, Noboru...
International Journal of Urology.  27 (2020)  11 - p. 952-959 , 2020
Link: https://doi.org/10.1111/..
 
?
15

Enzalutamide versus flutamide for castration-resistant pros..:

Iguchi, Taro ; Tamada, Satoshi ; Kato, Minoru...
BMC Cancer.  19 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
1-15